IDNNA

IDNNA
Clinical data
Other names	4-Iodo-2,5-dimethoxy-N,N-dimethylamphetamine; 2,5-Dimethoxy-4-iodo-N,N-dimethylamphetamine; N,N-Dimethyl-DOI
Routes of; administration	Oral
ATC code	None;
Pharmacokinetic data
Duration of action	Unknown
Identifiers
	IUPAC name 1-(4-iodo-2,5-dimethoxyphenyl)-N,N-dimethylpropan-2-amine;
CAS Number	85563-10-6 ;
PubChem CID	135056;
ChemSpider	119009 ;
UNII	M6Q9NK9RFD;
ChEMBL	ChEMBL11043 ;
CompTox Dashboard (EPA)	DTXSID901006121 ;
Chemical and physical data
Formula	C13H20INO2
Molar mass	349.212 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Ic1cc(OC)c(cc1OC)CC(N(C)C)C;
	InChI InChI=1S/C13H20INO2/c1-9(15(2)3)6-10-7-13(17-5)11(14)8-12(10)16-4/h7-9H,6H2,1-5H3 ; Key:XBCUSBRGRALQID-UHFFFAOYSA-N ;
	(verify)

IDNNA, also known as 4-iodo-2,5-dimethoxy-N,N-dimethylamphetamine or as N,N-dimethyl-DOI, is a lesser-known psychoactive drug and a substituted amphetamine.^[1] It is also the N,N-dimethyl analogue of DOI.^[1]

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), the minimum dose is listed as 2.6 mg and the duration as unknown.^[1] IDNNA produces few to no effects.^[1]

Society and culture

Legal status

Canada

IDNNA is a controlled substance in Canada under phenethylamine blanket-ban language.^[2]

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.^[3]

References

^ ^a ^b ^c ^d ^e ^f IDNNA Entry in PiHKAL
^ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.

External links

IDNNA - Isomer Design

[PiHKAL-1] ^ ^a ^b ^c ^d ^e ^f IDNNA Entry in PiHKAL

[CDSA-2] "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.

[3] "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.

[1]

[2]

[3]